Dakum PS - Search Results

1

In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix.

Datir R, Kemp S, El Bouzidi K, Mlchocova P, Goldstein R, Breuer J, Towers GJ, Jolly C, Quiñones-Mateu ME, Dakum PS, Ndembi N, Gupta RK. Datir R, et al. Among authors: dakum ps. mBio. 2020 Nov 3;11(6):e02036-20. doi: 10.1128/mBio.02036-20. mBio. 2020. PMID: 33144375 Free PMC article.

2

Update on HIV-1 acquired and transmitted drug resistance in Africa.

Ssemwanga D, Lihana RW, Ugoji C, Abimiku A, Nkengasong J, Dakum P, Ndembi N. Ssemwanga D, et al. AIDS Rev. 2015 Jan-Mar;17(1):3-20. AIDS Rev. 2015. PMID: 25427100 Review.

3

Improved Performance of COBAS AmpliPrep/COBAS TaqMan Version 2.0 Assay Over Amplicor Monitor Version 1.5 in the Quantification of HIV-1 RNA Viral Load in Abuja, Nigeria.

Abubakar A, Ndembi N, Ogbanufe O, Inalegwu A, Wilson S, Ebagua I, Peters S, Chime C, Dakum P, Abimiku AG. Abubakar A, et al. Curr HIV Res. 2015;13(4):262-7. doi: 10.2174/1570162x13666150121112139. Curr HIV Res. 2015. PMID: 25613132

4

Adherence to Anti-Retroviral Therapy in North Central Nigeria.

Avong YK, van Wyk B, Njab J, Abimiku AG, Ndembi N, Okuma J, Ogbanufe O, Ekong E, Dakum P, Blattner WA. Avong YK, et al. Curr HIV Res. 2015;13(4):268-78. doi: 10.2174/1570162x13666150202094120. Curr HIV Res. 2015. PMID: 25642849

5

Correlates of Patient Retention in HIV Care and Treatment Programs in Nigeria.

Ugoji C, Okere N, Dakum P, Ake-Uzoigwe R, Igboelina D, Ndembi N, Ekong E, Charurat M, Blattner WA. Ugoji C, et al. Curr HIV Res. 2015;13(4):300-7. doi: 10.2174/1570162x13999150317155348. Curr HIV Res. 2015. PMID: 25777516

6

Doing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria.

Avong YK, Isaakidis P, Hinderaker SG, Van den Bergh R, Ali E, Obembe BO, Ekong E, Adebamowo C, Ndembi N, Okuma J, Osakwe A, Oladimeji O, Akang G, Obasanya JO, Eltayeb O, Agbaje AV, Abimiku A, Mensah CO, Dakum PS. Avong YK, et al. Among authors: dakum ps. PLoS One. 2015 Mar 17;10(3):e0120161. doi: 10.1371/journal.pone.0120161. eCollection 2015. PLoS One. 2015. PMID: 25781958 Free PMC article.

7

Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin, Nigeria.

Nwofor AC, Nyamngee A, Nwabuisi C, Iwakun M, Gidado M, Mensah C, Dakum P, Agbede OO, Ndembi N, Blattner WA, Abimiku AG. Nwofor AC, et al. Curr HIV Res. 2015;13(4):308-14. doi: 10.2174/1570162x13666150407143147. Curr HIV Res. 2015. PMID: 25845392

8

Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention.

Coker M, Etiebet MA, Chang H, Awwal G, Jumare J, Musa BM, Babashani M, Habib AG, Dakum P, Abimiku AG, Charurat ME, Blattner WA, Eng M, Ndembi N. Coker M, et al. Curr HIV Res. 2015;13(4):279-85. doi: 10.2174/1570162x13666150407143838. Curr HIV Res. 2015. PMID: 25845393 Clinical Trial.

9

Active tracking of rejected dried blood samples in a large program in Nigeria.

Inalegwu A, Phillips S, Datir R, Chime C, Ozumba P, Peters S, Ogbanufe O, Mensah C, Abimiku A, Dakum P, Ndembi N. Inalegwu A, et al. World J Virol. 2016 May 12;5(2):73-81. doi: 10.5501/wjv.v5.i2.73. World J Virol. 2016. PMID: 27175352 Free PMC article.

10

Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics.

Volz EM, Ndembi N, Nowak R, Kijak GH, Idoko J, Dakum P, Royal W, Baral S, Dybul M, Blattner WA, Charurat M. Volz EM, et al. Virus Evol. 2017 Jul 28;3(2):vex014. doi: 10.1093/ve/vex014. eCollection 2017 Jul. Virus Evol. 2017. PMID: 28775893 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page